Johnson & Johnson expects nod for Covid vaccine by early 2021: Paul Stoffels, chief scientific officer, J&J
Posted by
www.biotecnika.org
Scientists and drug companies across the world are accelerating
various treatments and vaccine options to tackle Covid-19, which has
claimed hundreds of thousands of lives and crippled the world economy.
J&J, along with companies like GSK-Sanofi, AstraZeneca, Moderna, and
Sinovac are in the forefront of the race for vaccine development.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/johnson-johnson-expects-nod-for-covid-vaccine-by-early-2021-paul-stoffels-chief-scientific-officer-jj/articleshow/76377908.cms
Subscribe to:
Post Comments (Atom)
Post a Comment